Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.
Somnath Mukhopadhyay(Brighton and Sussex Medical School), R. E. Olver(University of Dundee), J I Cater(University of Dundee), Meenu Singh(All India Institute of Medical Sciences Raipur), M E Franklin(University of Dundee), S. Ogston(University of Dundee)
Cited by 113
Related Papers
Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study
|The Lancet|2021|465
Community health workers for non-communicable diseases prevention and control in developing countries: Evidence and implications
|PLoS ONE|2017|300
Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis
|Archives of Disease in Childhood|2005|215
Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
|PLoS ONE|2020|155
Inhaled antibiotics for long-term therapy in cystic fibrosis
|Cochrane Database of Systematic Reviews|2011|128